Notes
Registre Gironí del Cor
incremental cost-effectiveness ratios
Reference
Ramirez de Arellano A, et al. Economic Evaluation of Cardio inCode, a Clinical-Genetic Function for Coronary Heart Disease Risk Assessment. Applied Health Economics and Health Policy : 28 Sep 2013. Available from: URL: http://dx.doi.org/10.1007/s40258-013-0053-x
Rights and permissions
About this article
Cite this article
Cardio inCode cost-effective tool for CHD risk assessment. PharmacoEcon Outcomes News 689, 8 (2013). https://doi.org/10.1007/s40274-013-0797-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0797-4